Philips Previews Five-Year Plan As Connected Care Returns Group To Growth In Q3
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.
You may also be interested in...
The US HHS has partially terminated a deal it made in April with Philips to manufacture 43,000 medical ventilators. The contract had been worth a whopping $646.7m.
Intact Vascular developed the Tack endovascular system to repair vascular dissections following peripheral balloon angioplasty.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.